About 2,913 results

ALLMedicine™ Allergic Conjunctivitis Center

Research & Reviews  459 results

Allergic conjunctivitis: a risk factor for recurrent herpes simplex virus infections in...
European Journal of Dermatology : EJD; Salonen J, Remitz A et. al.

Dec 6th, 2022 - Patients with atopic dermatitis have an increased risk of herpes simplex virus (HSV) infections. We carried out a retrospective, cross-sectional study to investigate the association of disease severity, concomitant atopic diseases and filaggrin mu...

Association of different digital media experiences with paediatric dry eye in China: a ...
BMJ Open; Ma J, Zhu H et. al.

Dec 1st, 2022 - To investigate the ocular surface effects of different digital media experiences in Chinese elementary school students. Population-based cross-sectional study was used. 14 randomly selected primary schools in Yuhuatai District, Nanjing, China PART...

Interleukin-33-activated neuropeptide CGRP-producing memory Th2 cells cooperate with so...
Immunity Okano M, Hirahara K et. al.

Oct 23rd, 2022 - Allergic conjunctivitis is a chronic inflammatory disease that is characterized by severe itch in the conjunctiva, but how neuro-immune interactions shape the pathogenesis of severe itch remains unclear. We identified a subset of memory-type patho...

Ocular Biodistribution of Once-Daily 0.6% Bilastine Eye Drops Reveals Highest Levels in...
Journal of Ocular Pharmacology and Therapeutics : the Off... Torrens I, Ganza Á et. al.

Oct 22nd, 2022 - Purpose: Bilastine is a second-generation antihistamine that has been shown to be effective for treatment of allergic conjunctivitis. The objective of this study was to evaluate the pharmacokinetics (PKs) and biodistribution of 0.6% bilastine pres...

Efficacy of Proactive Topical Antihistamine Use in Patients with Seasonal Allergic Conj...
Advances in Therapy; Fukushima A, Miyazaki D et. al.

Oct 17th, 2022 - Topical antihistamines are often instilled symptomatically to control patients' eye allergy symptoms. The purpose of this study was to evaluate the effectiveness of proactive and as-needed use of antihistamine eye drops in controlling symptoms and...

see more →

Drugs  525 results see all →

Clinicaltrials.gov  120 results

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

Oct 14th, 2022 - To evaluate the efficacy of Combo (Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution) compared to its individual components and vehicle in a population of subjects with allergic conjunctivitis:

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis

Sep 2nd, 2022 - At Visit 1, subjects will sign the informed consent and an allergic skin test will be performed, if required. Each qualifying subject will undergo a bilateral conjunctival allergen challenge (Ora-CAC®) titration using an allergen they had a positi...

The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis

May 10th, 2022 - The INVIGORATE 2 Trial: A single-center, randomized, double-masked, crossover design, vehicle-controlled, Phase 3 clinical trial to assess the efficacy and safety of reproxalap ophthalmic solution (0.25%) compared to vehicle in subjects with seaso...

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

May 3rd, 2022 - This is a single-center, randomized, double-masked, parallel study. In this clinical study, the efficacy comparison between Pataday® Once Daily Relief Extra Strength and Claritin® Tablets 24-Hour will be made using the Ora-CAC model, a validated c...

Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies

Apr 27th, 2022 - The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of allergic conjunctivitis using an antigen challenge model

see more →

News  55 results

Dupilumab-Associated Ocular Surface Disease in Patients With AD: Unravelling the Link

Oct 21st, 2022 - MONTREAL — Ocular surface disease (OSD) in patients with atopic dermatitis (AD) treated with dupilumab may be exacerbated rather than caused by the therapy, according to a study presented at the annual meeting of the International Society of Atopi...

Immunotherapy for Allergic Rhinitis and Asthma Has Lasting Effects

Oct 13th, 2022 - Allergen immunotherapy (AIT) for allergic rhinitis and asthma is effective long-term, according to a literature review of real-world evidence by researchers in Germany and Poland. "Real-world data for AIT complement those from randomized controlle...

Study Links Poor Physical Fitness to Children's Eye Allergies

Oct 4th, 2022 - CHICAGO, Illinois — Children who are more physically fit seem to be less prone to eye allergies, according to a study of more than 1 million 10-year-olds in Taiwan that was reported at the annual meeting of the American Academy of Ophthalmology (A...

New Nasal Spray Approved for Nasal and Ocular Seasonal Allergic Rhinitis

Sep 7th, 2022 - Patients with both nasal and ocular symptoms of seasonal allergic rhinitis (SAR) have a new treatment option that combines olopatadine hydrochloride and mometasone furoate in the form of a nasal spray. Ryaltris (Hikma Pharmaceuticals PLC and Glenm...

Unilateral eye irritation
MDedge Family Medicine;

Apr 28th, 2022 - Physical examination revealed an irregularly shaped conjunctival cyst on the lateral (temporal) field of the right eye. (This diagnosis is usually made based on the clinical examination alone.

see more →

Patient Education  6 results see all →